Renovos Biologics

Renovos Biologics is a regenerative medicine company focused on transforming orthopedic treatments through its proprietary Renovite nanoclay platform. Spun out from the University of Southampton, the company specializes in the localized delivery of biologics to promote tissue repair while minimizing systemic side effects. The Renovite technology acts as a synthetic injectable scaffold that binds therapeutic agents like bone morphogenetic proteins (BMPs) with high affinity, allowing for ultra-low dose administration. This approach addresses the safety concerns associated with high-dose BMP treatments, such as ectopic bone growth and inflammation. The company's lead development programs target spinal fusion and difficult-to-heal bone fractures. By providing a biodegradable environment that supports cell infiltration, Renovos aims to improve outcomes in complex bone repair surgeries.